Literature DB >> 27895174

Human Lung Fibroblasts Present Bacterial Antigens to Autologous Lung Th Cells.

Andrew J Hutton1, Marta E Polak1, C Mirella Spalluto1, Joshua C Wallington1, Chris Pickard1, Karl J Staples2, Jane A Warner1, Tom M A Wilkinson1,3.   

Abstract

Lung fibroblasts are key structural cells that reside in the submucosa where they are in contact with large numbers of CD4+ Th cells. During severe viral infection and chronic inflammation, the submucosa is susceptible to bacterial invasion by lung microbiota such as nontypeable Haemophilus influenzae (NTHi). Given their proximity in tissue, we hypothesized that human lung fibroblasts play an important role in modulating Th cell responses to NTHi. We demonstrate that fibroblasts express the critical CD4+ T cell Ag-presentation molecule HLA-DR within the human lung, and that this expression can be recapitulated in vitro in response to IFN-γ. Furthermore, we observed that cultured lung fibroblasts could internalize live NTHi. Although unable to express CD80 and CD86 in response to stimulation, fibroblasts expressed the costimulatory molecules 4-1BBL, OX-40L, and CD70, all of which are related to memory T cell activation and maintenance. CD4+ T cells isolated from the lung were predominantly (mean 97.5%) CD45RO+ memory cells. Finally, cultured fibroblasts activated IFN-γ and IL-17A cytokine production by autologous, NTHi-specific lung CD4+ T cells, and cytokine production was inhibited by a HLA-DR blocking Ab. These results indicate a novel role for human lung fibroblasts in contributing to responses against bacterial infection through activation of bacteria-specific CD4+ T cells.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27895174     DOI: 10.4049/jimmunol.1600602

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  CD70 Activation Decreases Pulmonary Fibroblast Production of Extracellular Matrix Proteins.

Authors:  Thi K Tran-Nguyen; Jianmin Xue; Carol Feghali-Bostwick; Frank C Sciurba; Daniel J Kass; Steven R Duncan
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

Review 2.  Functional genomics of stromal cells in chronic inflammatory diseases.

Authors:  Kamil Slowikowski; Kevin Wei; Michael B Brenner; Soumya Raychaudhuri
Journal:  Curr Opin Rheumatol       Date:  2018-01       Impact factor: 5.006

3.  Versatile workflow for cell type-resolved transcriptional and epigenetic profiles from cryopreserved human lung.

Authors:  Maria Llamazares-Prada; Elisa Espinet; Vedrana Mijošek; Uwe Schwartz; Pavlo Lutsik; Raluca Tamas; Mandy Richter; Annika Behrendt; Stephanie T Pohl; Naja P Benz; Thomas Muley; Arne Warth; Claus Peter Heußel; Hauke Winter; Jonathan J M Landry; Felix Jf Herth; Tinne Cj Mertens; Harry Karmouty-Quintana; Ina Koch; Vladimir Benes; Jan O Korbel; Sebastian M Waszak; Andreas Trumpp; David M Wyatt; Heiko F Stahl; Christoph Plass; Renata Z Jurkowska
Journal:  JCI Insight       Date:  2021-03-22

Review 4.  The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells.

Authors:  Tom J Harryvan; Sabine de Lange; Lukas J A C Hawinkels; Els M E Verdegaal
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

Review 5.  Interrelation Between Fibroblasts and T Cells in Fibrosing Interstitial Lung Diseases.

Authors:  Yunxin Lai; Xinru Wei; Ting Ye; Lilin Hang; Ling Mou; Jin Su
Journal:  Front Immunol       Date:  2021-11-05       Impact factor: 7.561

Review 6.  Interrupting the Conversation: Implications for Crosstalk Between Viral and Bacterial Infections in the Asthmatic Airway.

Authors:  Jodie Ackland; Alastair Watson; Tom M A Wilkinson; Karl J Staples
Journal:  Front Allergy       Date:  2021-10-26

7.  Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus.

Authors:  Grace E Cooper; Kristoffer Ostridge; Salim I Khakoo; Tom M A Wilkinson; Karl J Staples
Journal:  Front Immunol       Date:  2018-07-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.